|
Name |
Pentatriacontane
|
Molecular Formula | C35H72 | |
IUPAC Name* |
pentatriacontane
|
|
SMILES |
CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCC
|
|
InChI |
InChI=1S/C35H72/c1-3-5-7-9-11-13-15-17-19-21-23-25-27-29-31-33-35-34-32-30-28-26-24-22-20-18-16-14-12-10-8-6-4-2/h3-35H2,1-2H3
|
|
InChIKey |
VHQQPFLOGSTQPC-UHFFFAOYSA-N
|
|
Synonyms |
Pentatriacontane; N-PENTATRIACONTANE; 630-07-9; KP13LFH341; NSC-125400; NSC 125400; UNII-KP13LFH341; DTXSID9074723; Pentatriacontane, analytical standard; LMFA11000584; MFCD00059397; NSC125400; ZINC62238214; CS-0454353; P0062; T72742; Q151158; 25E3ABFD-53A7-41A8-9766-C537F92EC7FF
|
|
CAS | 630-07-9 | |
PubChem CID | 12413 | |
ChEMBL ID | NA |
Chemical Classification: |
|
|
---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference | |
---|---|---|---|---|---|---|---|---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference |
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name |
Molecular Weight: | 492.9 | ALogp: | 18.6 |
HBD: | 0 | HBA: | 0 |
Rotatable Bonds: | 32 | Lipinski's rule of five: | Rejected |
Polar Surface Area: | 0.0 | Aromatic Rings: | 0 |
Heavy Atoms: | 35 | QED Weighted: | 0.065 |
Caco-2 Permeability: | -5.649 | MDCK Permeability: | 0.00000114 |
Pgp-inhibitor: | 0 | Pgp-substrate: | 0 |
Human Intestinal Absorption (HIA): | 0.004 | 20% Bioavailability (F20%): | 0.027 |
30% Bioavailability (F30%): | 1 |
Blood-Brain-Barrier Penetration (BBB): | 0.001 | Plasma Protein Binding (PPB): | 104.77% |
Volume Distribution (VD): | 6.195 | Fu: | 0.46% |
CYP1A2-inhibitor: | 0.015 | CYP1A2-substrate: | 0.1 |
CYP2C19-inhibitor: | 0.073 | CYP2C19-substrate: | 0.047 |
CYP2C9-inhibitor: | 0.005 | CYP2C9-substrate: | 0.985 |
CYP2D6-inhibitor: | 0.009 | CYP2D6-substrate: | 0.007 |
CYP3A4-inhibitor: | 0.089 | CYP3A4-substrate: | 0.006 |
Clearance (CL): | 4.115 | Half-life (T1/2): | 0.002 |
hERG Blockers: | 0.553 | Human Hepatotoxicity (H-HT): | 0.002 |
Drug-inuced Liver Injury (DILI): | 0.535 | AMES Toxicity: | 0.01 |
Rat Oral Acute Toxicity: | 0.007 | Maximum Recommended Daily Dose: | 0.063 |
Skin Sensitization: | 0.987 | Carcinogencity: | 0.009 |
Eye Corrosion: | 0.998 | Eye Irritation: | 0.921 |
Respiratory Toxicity: | 0.102 |
Similar NPs | Similar Drugs | ||||||
---|---|---|---|---|---|---|---|
NPs ID | NPs 2D Structure | Similarity Score | TTD ID | Drug 2D Structure | Similarity Score | ||
ENC000576 | 0.971 | D00AOJ | 0.574 | ||||
ENC000381 | 0.913 | D00STJ | 0.382 | ||||
ENC000437 | 0.883 | D00FGR | 0.359 | ||||
ENC000541 | 0.873 | D07ILQ | 0.358 | ||||
ENC000443 | 0.854 | D0Z1QC | 0.351 | ||||
ENC001204 | 0.838 | D01NTX | 0.347 | ||||
ENC000436 | 0.825 | D0Z5SM | 0.319 | ||||
ENC000435 | 0.796 | D06KDP | 0.311 | ||||
ENC000559 | 0.792 | D05ZPL | 0.292 | ||||
ENC001705 | 0.791 | D0T9TJ | 0.288 |